Hims & Hers Completes Acquisition of Eucalyptus, Advancing Position as the World's Largest Consumer Health Platform
Entering Australia for the first time, Hims & Hers will combine scale, technology, and clinical expertise to make personalised, whole-body care more accessible to every Australian
Hims & Hers Health, Inc. has completed its acquisition of Eucalyptus – the parent company of Juniper, Pilot, Kin, and Software – advancing its position as the world's largest consumer health platform and marking its official entry into Australia. This milestone puts the full weight of Hims & Hers' technology, data, and clinical infrastructure behind a platform that has already transformed how over half a million Australians have accessed care.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260602264452/en/
Entering Australia for the first time, Hims & Hers will combine scale, technology, and clinical expertise to make personalised, whole-body care more accessible to every Australian
Over a quarter of Australians continue to face longer than normal wait times for appointments, having to navigate significant health challenges without adequate support. Since 2019, Eucalyptus has served over 550,0001 Australians through a portfolio of brands, addressing some of the country's most common and underserved health needs, ranging from weight management and reproductive care to men's sexual health. Through this acquisition, Hims & Hers brings additional resources and operational expertise, giving more Australians access to personalised, evidence-based care for the conditions that matter most to them.
"Australians are among the most health-conscious consumers in the world, and Eucalyptus has already begun redefining what healthcare access can look like," said Andrew Dudum, co-founder and CEO of Hims & Hers. "Now our opportunity is to expand on that foundation, help more people tackle the health challenges that Australians face every day under a unified platform, and deliver access to the kind of whole-body, preventive care Australians deserve."
A local clinical approach remains integral to how Hims & Hers operates in Australia. Customers will continue to be connected with Australian providers who understand the healthcare landscape they are navigating, bringing the local expertise and clinical rigour this kind of care demands. For customers already receiving care through Juniper, Pilot, Kin, or Software, treatment continues uninterrupted. Joining Hims & Hers gives the team the resources and reach to keep building on a model customers have come to trust, with more behind it than ever before.
"We built Eucalyptus in Australia because we believed Australians deserved better. More personalised, more proactive, more accessible care," said Tim Doyle, Senior Vice President of International at Hims & Hers and former CEO of Eucalyptus. "More than half a million customers around the world proved us right. Now, through this acquisition by Hims & Hers, an Australian idea drives a global movement forward, one that will reach more people, go deeper than ever before, and change what healthcare looks like everywhere."
____________________ |
1 As of May 2026. Customer defined as a user having purchased a program through a Eucalyptus brand. |
About Hims & Hers Health, Inc.
Hims & Hers is the leading health and wellness platform on a mission to help the world feel great through the power of better health. We believe how you feel in your body and mind transforms how you show up in life. That's why we're building a future where nothing stands in the way of harnessing this power. Hims & Hers normalizes health & wellness challenges—and innovates on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so the company provides access to personalised care designed for results. For more information, please visit www.hims.com and www.forhers.com.
About Eucalyptus
Eucalyptus builds and operates a house of digital healthcare companies. Founded in 2019 by Tim Doyle, Benny Kleist, Alexey Mitko and Charlie Gearside, it is now Australia's largest digital health provider and one of Australia's fastest growing companies. Eucalyptus has facilitated nearly two million consultations across Australia, the UK, Germany, Japan, and Canada, and is the first telehealth company in Australia accredited by the Australian Council on Healthcare Standards (ACHS) against the EQuIP6 standards for safety and quality of clinical services. For more information, visit Eucalyptus's website or follow their page on LinkedIn.
Cautionary Note Regarding Forward-Looking Statements
This press release contains statements that may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and "forward-looking information" within the meaning of applicable Australian securities legislation (collectively, "forward-looking statements"). The forward-looking statements contained in this press release are expressly qualified by this cautionary statement and readers are cautioned not to put undue reliance on them. These forward-looking statements can be identified by the use of forward-looking terminology, including the words "believes," "estimates," "anticipates," "expects," "intends," "plans," "assume," "may," "can," "will," "likely," "potential," "occur," "projects," "predicts," "continue," "goal," "objective," "strategy," "future," "forecast," "target," "outlook," "opportunity," "project," "confidence," "foundation," "groundwork," or "could," "should," "would," or, in each case, their negative or other variations or comparable terminology. There can be no assurance that actual results will not materially differ from expectations. Such statements include, but are not limited to, statements regarding Hims & Hers' expansion into Australia, the anticipated benefits of the acquisition of Eucalyptus, the expected timing and potential launch of new products or offerings, and assumptions relating to the foregoing. These forward-looking statements are based on management's current expectations, but actual results may differ materially due to various factors.
Forward-looking statements are neither historical facts nor assurances of future performance. Instead, the forward-looking statements contained in this press release are based on our current expectations, assumptions and beliefs concerning future developments and their potential effects on us. Future developments affecting us may not be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) and other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, uncertainties relating to the integration of Eucalyptus; our ability to successfully expand into new markets or specialties; our ability to launch new products or offerings on expected timelines or at all; expectations regarding market acceptance, user experience and customer retention; changes in healthcare, consumer protection or privacy laws; increased scrutiny from regulators; the impact of general economic, business, or financial conditions; and other factors described in the Risk Factors and other sections of our most recently filed Quarterly Report on Form 10-Q, our most recently filed Annual Report on Form 10-K, and other current and periodic reports we file from time to time with the Securities and Exchange Commission as well as additional risks and uncertainties inherent to Hims & Hers' business, not currently known by Hims & Hers, that are out of Hims & Hers's control or that Hims & Hers currently deems to be immaterial, which could also have a material adverse effect on Hims & Hers or on its ability to successfully integrate the acquisition of Eucalyptus.
Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. The forward-looking statements contained in this press release are made only as of the date of this press release. We undertake no obligation (and expressly disclaim any obligation) to update or revise any forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in the forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. If Hims & Hers updates any one or more forward-looking statements, no inference should be drawn that Hims & Hers will make additional updates with respect to those forward-looking statements. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. We caution you that forward-looking statements are not guarantees of future performance and that our actual results may differ materially from those made in or suggested by the forward-looking statements contained in this press release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260602264452/en/
Press Contact
Susan Cadrecha
press@forhims.com